-
HD2026 Milton Wexler Biennial Symposium Day 3
Latest News
-
HD2026 Milton Wexler Biennial Symposium Day 2
⏱️ 23 min read | Day 2 of #HD2026 brought us updates on the mechanics of somatic instability, new ways to track HD in people, AI tools to help drive research forward, and developments in our understanding of the HTT protein. Catch up right here.
-
Is a new Huntington’s Disease drug study on the right Trk?
A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics
-
DNA shutdown proteins in Huntington's disease: More than meets the eye
Blocking HDAC4 improves Huntington's disease-related problems in cells and mice – but in a surprising way
-
More evidence points to Huntington's disease exercise benefit
Two studies show exercise benefits for some symptoms of Huntington's disease. Just don't believe everything you read.
-
Do dairy foods accelerate Huntington's disease?
Is there a link between consuming dairy food and earlier onset in people with the Huntington's disease mutation?
-
Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
The news has recently been full of stories about CRISPR, a new "jaw-dropping" DNA-editing technology. Hype or hope?
-
New study sheds light on regional degeneration in HD
Why do certain brain cells die in HD? New research suggests is may be due to the efficiency of cellular recycling
-
Buzzilia Video: Day 3
Video from day 3 of Buzzilia: nightly news, interviews and features from the HD World Congress 2013 in Brazil
-
Buzzilia Video: Day 2
Video from day 2 of Buzzilia: nightly news, interviews and features from the HD World Congress 2013 in Brazil
-
What the 'big neurodegeneration breakthrough' means for Huntington's disease
Are recent findings in mice injected with 'prions' as important for Huntington's disease as widely reported?
-
The sweet lowdown: Huntington's disease brains use sugar differently
New observations suggest that the brains of HD mutation carriers consume energy differently. Do we care? (Yes!)
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Show 9 more Show less
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
